Immuron (IMRN) Change in Cash (2016 - 2024)
Immuron (IMRN) posted quarterly Change in Cash of -$2.8 million for Q4 2024, down 50.08% year-on-year from -$5.6 million in Q1 2024, and down 50.08% on a QoQ basis from -$1.9 million in Q4 2023.
Immuron (IMRN) Change in Cash (2016 - 2024) Analysis & Trends
Immuron (IMRN) has reported Change in Cash for 9 consecutive years, with -$2.8 million the latest figure, recorded in Q4 2024.
- Quarterly Change in Cash fell 50.08% year-over-year to -$2.8 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $8.6 million (down 75.7% YoY) and the FY2025 annual result came in at -$8.8 million, down 59.19% from the prior year.
- Change in Cash eased to -$2.8 million in Q4 2024 per IMRN's latest filing, from -$1.9 million in the prior quarter.
- Over the last five years, Change in Cash for IMRN reached as high as $23.9 million in Q4 2020 and fell as low as -$3.6 million in Q4 2022.
- A 5-year average of $6.5 million and a median of -$1.9 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2020 — Change in Cash surged 8005.28% — and 2022, when it plunged 121.44%.
- Year by year, Change in Cash stood at $23.9 million in 2020, then decreased by 29.38% to $16.9 million in 2021, then plunged by 121.44% to -$3.6 million in 2022, then jumped by 48.2% to -$1.9 million in 2023, then slumped by 50.08% to -$2.8 million in 2024.
- According to Business Quant data, Change in Cash over the past three periods registered -$2.8 million, -$1.9 million, and -$3.6 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.81 Mn |
| Dec 31, 2023 | -1.87 Mn |
| Dec 31, 2022 | -3.62 Mn |
| Dec 31, 2021 | 16.87 Mn |
| Dec 31, 2020 | 23.89 Mn |
| Dec 31, 2019 | -302,214.00 |
| Dec 31, 2018 | -424,901.00 |
| Dec 31, 2017 | -3.43 Mn |
| Dec 31, 2016 | 574,087.92 |